Literature DB >> 23645679

p39, the primary activator for cyclin-dependent kinase 5 (Cdk5) in oligodendroglia, is essential for oligodendroglia differentiation and myelin repair.

Andrew N Bankston1, Wenqi Li, Hui Zhang, Li Ku, Guanglu Liu, Filomena Papa, Lixia Zhao, James A Bibb, Franca Cambi, Seema K Tiwari-Woodruff, Yue Feng.   

Abstract

Cyclin-dependent kinase 5 (Cdk5) plays key roles in normal brain development and function. Dysregulation of Cdk5 may cause neurodegeneration and cognitive impairment. Besides the well demonstrated role of Cdk5 in neurons, emerging evidence suggests the functional requirement of Cdk5 in oligodendroglia (OL) and CNS myelin development. However, whether neurons and OLs employ similar or distinct mechanisms to regulate Cdk5 activity remains elusive. We report here that in contrast to neurons that harbor high levels of two Cdk5 activators, p35 and p39, OLs express abundant p39 but negligible p35. In addition, p39 is selectively up-regulated in OLs during differentiation along with elevated Cdk5 activity, whereas p35 expression remains unaltered. Specific knockdown of p39 by siRNA significantly attenuates Cdk5 activity and OL differentiation without affecting p35. Finally, expression of p39, but not p35, is increased during myelin repair, and remyelination is impaired in p39(-/-) mice. Together, these results reveal that neurons and OLs harbor distinct preference of Cdk5 activators and demonstrate important functions of p39-dependent Cdk5 activation in OL differentiation during de novo myelin development and myelin repair.

Entities:  

Keywords:  Cyclin-dependent Kinase 5 (Cdk5); Differentiation; Gene Regulation; Glia; Myelin; Neurons; Oligodendroglia; p39

Mesh:

Substances:

Year:  2013        PMID: 23645679      PMCID: PMC3689949          DOI: 10.1074/jbc.M113.453688

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  The role of miR-103 and miR-107 in regulation of CDK5R1 expression and in cellular migration.

Authors:  Silvia Moncini; Alessandro Salvi; Paola Zuccotti; Gabriella Viero; Alessandro Quattrone; Sergio Barlati; Giuseppina De Petro; Marco Venturin; Paola Riva
Journal:  PLoS One       Date:  2011-05-23       Impact factor: 3.240

Review 2.  White matter integrity and vulnerability to Alzheimer's disease: preliminary findings and future directions.

Authors:  Brian T Gold; Nathan F Johnson; David K Powell; Charles D Smith
Journal:  Biochim Biophys Acta       Date:  2011-07-23

3.  The QKI-PLP pathway controls SIRT2 abundance in CNS myelin.

Authors:  H Zhu; L Zhao; E Wang; N Dimova; G Liu; Y Feng; F Cambi
Journal:  Glia       Date:  2011-09-21       Impact factor: 7.452

Review 4.  Cdk5: a multifaceted kinase in neurodegenerative diseases.

Authors:  Zelda H Cheung; Nancy Y Ip
Journal:  Trends Cell Biol       Date:  2011-12-20       Impact factor: 20.808

Review 5.  Cyclin-dependent kinases in brain development and disease.

Authors:  Susan C Su; Li-Huei Tsai
Journal:  Annu Rev Cell Dev Biol       Date:  2011-07-05       Impact factor: 13.827

6.  Phosphoregulation of the RNA-binding protein Hu antigen R (HuR) by Cdk5 affects centrosome function.

Authors:  Natalia Filippova; Xiuhua Yang; Peter King; L Burt Nabors
Journal:  J Biol Chem       Date:  2012-07-24       Impact factor: 5.157

7.  Hypomyelination phenotype caused by impaired differentiation of oligodendrocytes in Emx1-cre mediated Cdk5 conditional knockout mice.

Authors:  Xiaojuan He; Satoru Takahashi; Hiromi Suzuki; Tsutomu Hashikawa; Ashok B Kulkarni; Katsuhiko Mikoshiba; Toshio Ohshima
Journal:  Neurochem Res       Date:  2011-01-06       Impact factor: 3.996

8.  Cyclin-dependent kinase 5 regulates endothelial cell migration and angiogenesis.

Authors:  Johanna Liebl; Sabine B Weitensteiner; György Vereb; Lili Takács; Robert Fürst; Angelika M Vollmar; Stefan Zahler
Journal:  J Biol Chem       Date:  2010-09-07       Impact factor: 5.157

9.  p35, the non-cyclin activator of Cdk5, protects podocytes against apoptosis in vitro and in vivo.

Authors:  Paul T Brinkkoetter; Jimmy S Wu; Takamoto Ohse; Ronald D Krofft; Bernhard Schermer; Thomas Benzing; Jeffrey W Pippin; Stuart J Shankland
Journal:  Kidney Int       Date:  2010-02-03       Impact factor: 10.612

Review 10.  Overcoming remyelination failure in multiple sclerosis and other myelin disorders.

Authors:  Stephen P J Fancy; Mark R Kotter; Emily P Harrington; Jeffrey K Huang; Chao Zhao; David H Rowitch; Robin J M Franklin
Journal:  Exp Neurol       Date:  2010-01-04       Impact factor: 5.330

View more
  12 in total

1.  The Cdk5 activator P39 specifically links muskelin to myosin II and regulates stress fiber formation and actin organization in lens.

Authors:  Brajendra K Tripathi; Douglas R Lowy; Peggy S Zelenka
Journal:  Exp Cell Res       Date:  2014-08-13       Impact factor: 3.905

2.  The Activators of Cyclin-Dependent Kinase 5 p35 and p39 Are Essential for Oligodendrocyte Maturation, Process Formation, and Myelination.

Authors:  Fucheng Luo; Jessie Zhang; Kathryn Burke; Robert H Miller; Yan Yang
Journal:  J Neurosci       Date:  2016-03-09       Impact factor: 6.167

3.  p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses.

Authors:  Wenqi Li; Megan E Allen; Yanfang Rui; Li Ku; Guanglu Liu; Andrew N Bankston; James Q Zheng; Yue Feng
Journal:  J Neurosci       Date:  2016-11-02       Impact factor: 6.167

4.  Protocols for Characterization of Cdk5 Kinase Activity.

Authors:  Anita Terse; Niranjana Amin; Bradford Hall; Manju Bhaskar; Binukumar B K; Elias Utreras; Tej K Pareek; Harish Pant; Ashok B Kulkarni
Journal:  Curr Protoc       Date:  2021-10

5.  Oligodendrocyte-specific loss of Cdk5 disrupts the architecture of nodes of Ranvier as well as learning and memory.

Authors:  Fucheng Luo; Jessie Zhang; Kathryn Burke; Rita R Romito-DiGiacomo; Robert H Miller; Yan Yang
Journal:  Exp Neurol       Date:  2018-05-02       Impact factor: 5.330

6.  Cyclin-dependent kinase 5 mediates adult OPC maturation and myelin repair through modulation of Akt and GsK-3β signaling.

Authors:  FuCheng Luo; Kathryn Burke; Christopher Kantor; Robert H Miller; Yan Yang
Journal:  J Neurosci       Date:  2014-07-30       Impact factor: 6.167

7.  Early postnatal in vivo gliogenesis from nestin-lineage progenitors requires cdk5.

Authors:  David Petrik; Sanghee Yun; Sarah E Latchney; Sohail Kamrudin; Junie A LeBlanc; James A Bibb; Amelia J Eisch
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

8.  Methotrexate combined with methylprednisolone for the recovery of motor function and differential gene expression in rats with spinal cord injury.

Authors:  Jian-Tao Liu; Si Zhang; Bing Gu; Hua-Nan Li; Shuo-Yu Wang; Shui-Yin Zhang
Journal:  Neural Regen Res       Date:  2017-09       Impact factor: 5.135

9.  Active Cdk5 Immunoprecipitation and Kinase Assay.

Authors:  Andrew N Bankston; Li Ku; Yue Feng
Journal:  Bio Protoc       Date:  2017-07-05

10.  Suppression of neuroinflammation in forebrain-specific Cdk5 conditional knockout mice by PPARγ agonist improves neuronal loss and early lethality.

Authors:  Elias Utreras; Ryusuke Hamada; Michaela Prochazkova; Anita Terse; Satoru Takahashi; Toshio Ohshima; Ashok B Kulkarni
Journal:  J Neuroinflammation       Date:  2014-02-05       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.